Implication of poly(ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism: Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 227-239

  Cosi, Cristina ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; BENZAMIDE; DNA; DNA BINDING PROTEIN; DOPAMINE; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN METABOLISM; CELL CULTURE; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; DOPAMINE RELEASE; ENERGY METABOLISM; MESENCEPHALON; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE;

ANIMALIA;

EID: 0033389550     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07998.x     Document Type: Conference Paper

References (17)

1. 1. Gaal, J.C., K.R. Smith & C.K. Pearson. 1987. Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolism. Trends Biochem. Sci. 12: 128-129.
2. 2. Carson, D.A., S. Seto, D.B. Wasson & C.J. Carrera. 1986. DNA strand breaks, NAD metabolism, and programmed cell death. Exp. Cell Res. 164: 273-281.
3. 3. Schraufstatter, I.U., P.A. Hyslop, D.B. Hinshaw, R.G. Spragg, L.A. Sklar & C.G. Cockrane. 1986. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 83: 4908-4912.
4. 4. Chan, P., L.E. Delanney, I. Irwin, J.W. Langston & D.A. Di Monte. 1991. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57: 348-351.
5. 5. Chan, P., J.W. Langston, I. Irwin, L.E. Delanney & D.A. Di Monte. 1993. 2-De-oxyglucose enhances 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-induced ATP loss in the mouse brain. J. Neurochem. 61: 610-616.
6. 6. Cosi, C., F. Colpaert, W. Koek, A. Degryse & M. Marien. 1996. Poly(ADP-ribose)polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res. 729: 264-269.
7. 7. NRC (National Research Council). 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press. Washington, DC.
8. + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly (ADP-ribose) polymerase inhibitor, benzamide. Brain Res. 809: 58-67.
9. 9. Marien, M.R., M. Briley & F. Colpaert. 1993. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur. J. Pharmacol. 236: 487-489.
10. +): regional dopamine neuron uptake, toxicity, and novel rotational behaviour following receptor proliferation. Eur. J. Pharmacol. 131: 199-209.
11. 11. Chan, P., D.A. Di Monte, J.J. Luo, L.E. Delanney, I. Irwin & J.W. Langston. 1994. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic toxicity. J. Neurochem. 62: 2484-2487.
12. 12. Castagnoli, K., S. Palmer, A. Anderson, T. Bueters & N. Castagnoli, JR. 1997. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem. Res. Toxicol. 10: 364-368.
13. 13. Market, S.P., J.N. Johannessen, C.C. Chiueh, R.S. Burns & M.A. Herkenham. 1984. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311: 464-466.
14. 14. Giovanni, A., P.K. Sonsalla & R.E. Heikkila. 1994. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium. J. Pharmacol. Exp. Ther. 270: 1008-1014.
15. 15. Westerink, B.H.C., J. Tuntler, G. Damsma, H. Rollema & J.B. de Vries. 1987. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedebergs Arch. Pharmacol. 336: 502-507.
16. 16. Chiueh, C.C., H. Miyake & M.-T. Peng. 1993. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60: 251-258.
17. 17. Wood, P.L. & C.A. Altar. 1988. Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol. Rev. 40: 163-187.